Domov › Levkemija › New York

Klinične študije za Levkemija v New York

26 študij za Levkemija išče udeležence na lokacijah v New York.

Mesta v New York

Uradno besedilo študije (angleško)

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Quetzal Site 4, Buffalo
Quetzal Site 2, The Bronx

Vključevanje udeležencevFaza 3

Starost 18–71 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07504458

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Montefiore Medical Center, New York

Vključevanje udeležencevFaza 1/2

30 Days · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT04065399

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Weill Cornell, New York
Clinical Research Allicance, Westbury

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT06824168

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 2

Starost 12 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06229912

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Research Site, Rochester

Vključevanje udeležencevFaza 3

Starost 18–18 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07509151

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

Columbia University Medical Center New York Presbyterian, New York

Vključevanje udeležencevFaza 2

Starost 1–18 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07354074

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07586618

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

State University of New York at Buffalo, Buffalo
Icahn School of Medicine at Mount Sinai, New York
Columbia University, New York
in še 1

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Roswell Park Comprehensive Cancer Center, Buffalo
Northwell Health, LLC PRIME, Lake Success
Memorial Sloan Kettering Cancer Center, New York
in še 3

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT06001788

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, New York

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT06137118

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

Vključevanje udeležencevFaza 1/2

Starost 13–90 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06533579

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

Albany Medical Center, Albany

Vključevanje udeležencevOpazovalna študija

Do 30 let · Vsi spoli · Posodobljeno 16. jul. 2026 · NCT04968834

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Weill Cornell Medicine - New York Presbyterian Hospital, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07216443

Hairy Cell Leukemia Patient Data Registry

University of Rochester /Wilmot Cancer Institute, Rochester

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 2. jul. 2026 · NCT02560883

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

CD4CAR for CD4+ Leukemia and Lymphoma

Albert Einstein Health Network, New York

Vključevanje udeležencevFaza 1

Starost 12 in več · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT03829540

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
in še 1

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT07356154

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Dren Investigational Site 1, New York
Dren Investigational Site 2, New York

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT05475925

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activities), New York
in še 1

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 26. maj 2026 · NCT07052916

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
University of Rochester, Rochester
Stony Brook University Medical Center, Stony Brook
in še 1

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 18. maj 2026 · NCT01790152